Photo: The MRS7145 photopharmaceutical is effective in animal models of the disease, according to research published in the Journal of Controlled Release./UB
A team led by the University of Barcelona has designed the first photopharmaceutical with therapeutic potential to fight against Parkinson’s. The compound, which is activated by light from the visible spectrum, has been tested in animal models. According to the authors, photosensitive drugs can act with greater spatial and temporal precision without generating harmful effects in the organism.
Francisco Ciruela, ...Read more